Dow Jones Newswires: Roche’s vision-loss drug Vabysmo gets EU nod

The approval from the European Commission–the EU’s executive arm–comes after four phase-3 studies showing vision gains and anatomical improvements in patients given the drug, Roche said.

Advertisements

Read More

Previous post UN General Assembly draws dictators, presidents as war hits Europe, threatens Asia – but climate remains focus
Next post 62 and 700: Judge, Pujols closing in on home run milestones